al-Bahar S, Pandita R, Hoffbrand A V
Department of Haematology, Kuwait Cancer Control Centre, Shuwaikh, Kuwait.
Acta Haematol. 1996;96(2):88-91. doi: 10.1159/000203722.
The complication of 'retinoic acid syndrome' occurs in 25-30% of patients with acute promyelocytic leukemia (APL) treated with all-transretinoic acid (ATRA). Early dexamethasone therapy has reduced mortality from this complication. No long-term sequel of the syndrome or its treatment with dexamethasone has been described. We report a patient with APL treated with ATRA who developed avascular necrosis of both femoral heads following treatment of retinoic acid syndrome with short-duration, high-dose dexamethasone.
25%至30%接受全反式维甲酸(ATRA)治疗的急性早幼粒细胞白血病(APL)患者会出现“维甲酸综合征”并发症。早期地塞米松治疗已降低了该并发症的死亡率。目前尚未有关于该综合征或其地塞米松治疗的长期后遗症的报道。我们报告了一名接受ATRA治疗的APL患者,在用短期、高剂量地塞米松治疗维甲酸综合征后发生了双侧股骨头缺血性坏死。